dostarlimab
gsk
['crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rectal', 'dostarlimab']
patients with locally advanced rectal cancer and tumors with dmmr have shown a remarkable response to treatment with the pd-1 inhibitor dostarlimab. #asco22 #precisionmedicine #crcsm
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.